Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -2.04
- Piotroski Score 1.00
- Grade Buy
- Symbol (MDWD)
- Company MediWound Ltd.
- Price $16.52
- Changes Percentage (-1.43%)
- Change -$0.24
- Day Low $16.48
- Day High $16.81
- Year High $24.00
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/26/2024
- Fiscal Year End N/A
- Average Stock Price Target $26.50
- High Stock Price Target $36.00
- Low Stock Price Target $25.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.36
- Trailing P/E Ratio -12.53
- Forward P/E Ratio -12.53
- P/E Growth -12.53
- Net Income $-6,716,000
Income Statement
Quarterly
Annual
Latest News of MDWD
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
MediWound's (NASDAQ:MDWD) investors will be pleased with their stellar 125% return over the last year
Investing without borrowing money limits potential losses. For example, MediWound Ltd. (NASDAQ:MDWD) shares have surged 125% in the last year but are 29% lower than three years ago. Analyzing the comp...
By Yahoo! Finance | 3 weeks ago -
Is MediWound (NASDAQ:MDWD) In A Good Position To Invest In Growth?
While some businesses may not initially make money, their stock value can still rise. Analyzing the cash burn rate of MediWound (NASDAQ:MDWD), it appears the company has a cash runway of 19 months des...
By Yahoo! Finance | 4 months ago
